Ultra low dose interleukin-2 therapy promotes a type 1 cytokine profile in vivo in patients with AIDS and AIDS-associated malignancies.

Ultra low dose interleukin-2 therapy promotes a type 1 cytokine profile in vivo in patients with AIDS and AIDS-associated malignancies.

Item
http://www.wikidata.org/entity/Q37379576
Safety and immunologic response of a viral vaccine to prostate-specific antigen in combination with radiation therapy when metronomic-dose interleukin 2 is used as an adjuvantImmune reconstitution of CD56(dim) NK cells in individuals with primary HIV-1 infection treated with interleukin-2.Regulation and function of T-cell-mediated immunity during Toxoplasma gondii infection.Type 1/Type 2 immunity in infectious diseases.Natural killer cell function is well preserved in asymptomatic human immunodeficiency virus type 2 (HIV-2) infection but similar to that of HIV-1 infection when CD4 T-cell counts fall.Prospects for IL-16 in the treatment of AIDS.Ontogeny and expansion of human natural killer cells: clinical implications.Potential mechanisms of human natural killer cell expansion in vivo during low-dose IL-2 therapy.Maintenance biotherapy with interleukin-2 and interferon for metastatic renal cell cancer.Astaxanthin, a Carotenoid, Stimulates Immune Responses by Enhancing IFN-γ and IL-2 Secretion in Primary Cultured Lymphocytes in Vitro and ex VivoSystemic administration of interleukin 2 enhances the therapeutic efficacy of dendritic cell-based tumor vaccinesMonitoring cytokine profiles during immunotherapy.Utilizing cytokines to function-enable human NK cells for the immunotherapy of cancer.Increased endosomal sorting of ligand to recycling enhances potency of an interleukin-2 analog.Activation of NF-kappaB in Mycobacterium tuberculosis- induced interleukin-2 receptor expression in mononuclear phagocytes.
P2860

Ultra low dose interleukin-2 therapy promotes a type 1 cytokine profile in vivo in patients with AIDS and AIDS-associated malignancies.

Item
http://www.wikidata.org/entity/Q37379576
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on March 1998
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Ultra low dose interleukin-2 t ...... AIDS-associated malignancies.
@en
Ultra low dose interleukin-2 t ...... AIDS-associated malignancies.
@nl
type
label
Ultra low dose interleukin-2 t ...... AIDS-associated malignancies.
@en
Ultra low dose interleukin-2 t ...... AIDS-associated malignancies.
@nl
prefLabel
Ultra low dose interleukin-2 t ...... AIDS-associated malignancies.
@en
Ultra low dose interleukin-2 t ...... AIDS-associated malignancies.
@nl
P1433
P1476
P2093
P2860
P304
P31
P356
P407
P433
P478
P577
P698
P921
P932
P356
P1433
P1476
Ultra low dose interleukin-2 t ...... AIDS-associated malignancies.
@en
P2093
P2860
P304
P31
P356
P407
P433
P478
P577
P698
P921
P932